Lack of interleukin‐6 in the tumor microenvironment augments type‐1 immunity and increases the efficacy of cancer immunotherapyYosuke Ohno, Hidemitsu Kitamura, Hideaki Yurino et al.|Cancer Science|2017Cited by 85